SMOFlipid: Clinical Trials

12 trials of SMOFlipid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 2 unknown, 2 withdrawn. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 5, Terminated 2, Unknown 2, Withdrawn 2, Recruiting 1

Follow SMOFlipid: new trials by email Literature Review of SMOFlipid trials Research Report on SMOFlipid

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
SMOFlipid® (lipid injectable emulsion) - Malnutrition, Child, Malnutrition
Phase 4RecruitingFresenius Kabi1002024-10-282026-10-22
Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
SMOFlipid, Lipofundin - Preterm Infant
Phase 4UnknownShanghai Jiao Tong University School of Medicine662020-02-012020-02-20
Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
Smoflipid, Intralipid, 20% - Malnutrition, Child
Phase 4TerminatedFresenius Kabi12019-12-182022-12-12
SMOFLipid in Patients Who Are Intralipid Intolerant
SMOFLipid, Standard therapy - Home Parenteral Nutrition, Short Bowel Syndrome
Phase 4WithdrawnMayo Clinic2017-02-012018-03-22
Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide
SMOFlipid®, Medialipide® - Preterm Neonates
Phase 4WithdrawnHospices Civils de Lyon2017-01-012019-07-24
The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis
Smoflipid ® - Sepsis Newborn
Phase 4CompletedMansoura University Children Hospital402016-02-012018-03-23
Lipids and Neurological Complications in Liver Transplantation
SMOF lipid (SMOFLIPID) pre treatment - Neurological Complications
Phase 4UnknownMansoura University802015-09-012017-03-27
Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population
Smoflipid, Médialipides - Dietary and Nutritional Therapies
Phase 4CompletedCentre Hospitalier Universitaire de Nice92015-06-012017-04-13
Preventing Cholestasis Using SMOFLipid®
SMOFLIPID, INTRALIPID - Cholestasis, Psychomotor Disorders, Developmental
Phase 4CompletedMedical University of Vienna2302012-06-012018-01-09
Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition
ClinOleic (baseline), ClinOleic + Omegaven, Lipoplus (baseline) - Parenteral Nutrition
Phase 4CompletedGeneral University Hospital, Prague242012-01-152017-05-11
Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions
SMOFlipid, Lipofundin - Intrahepatic, Cholestasis
Phase 4TerminatedCentro Hospitalar de Lisboa Central522011-08-012017-07-13
Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function
SMOFlipid®, 2-ClinOleic 20%® - Inflammatory Response, Hepatic Function
Phase 4CompletedKlinikum Ludwigshafen422006-12-012009-12-03

Conditions studied

Hyperphagia (6)  ·  Child Nutrition Disorders (2)  ·  Malnutrition (2)  ·  Premature Birth (2)  ·  Cholestasis (1)  ·  Cholestasis, Intrahepatic (1)  ·  Intestinal Failure (1)  ·  Neonatal Sepsis (1)  ·  Neurotoxicity Syndromes (1)  ·  Psychomotor Disorders (1)  ·  Sepsis (1)  ·  Short Bowel Syndrome (1)

Sponsors

Fresenius Kabi (2)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Centro Hospitalar de Lisboa Central (1)  ·  General University Hospital, Prague (1)  ·  Hospices Civils de Lyon (1)  ·  Klinikum Ludwigshafen (1)  ·  Mansoura University (1)  ·  Mansoura University Children Hospital (1)  ·  Mayo Clinic (1)  ·  Medical University of Vienna (1)  ·  Shanghai Jiao Tong University School of Medicine (1)

Countries

United States (3)  ·  Egypt (2)  ·  France (2)  ·  Austria (1)  ·  Czechia (1)  ·  Germany (1)

Top investigators

Jeffrey Rudolph, MD (2)  ·  Amr M Yassen, MD (1)  ·  Andreas Repa, MD (1)  ·  Frantisek Novak, MD, PhD (1)  ·  Luis Pereira-da-Silva, MD, PhD (1)  ·  Manpreet S Mundi (1)  ·  Nadja Haiden, MD (1)  ·  Swen N. Piper, Dr. med. (1)  ·  Yahya M Wahba, MD (1)  ·  Ying Wang, Phd (1)

Results publications

PMID 20393276, PMID 10022591, PMID 11906641, PMID 12710654, PMID 15269615, PMID 15585684, PMID 16254497, PMID 16632649, PMID 18310188, PMID 19571170, PMID 19687773, PMID 20398379, PMID 22319539, PMID 22683686, PMID 22942104, PMID 23398476, PMID 24961544, PMID 25722954, PMID 26146621, PMID 26630252, PMID 28630687, PMID 29269199, PMID 29415837, PMID 31030946, PMID 32590001, PMID 36257349